Four new complaints have been filed in PA federal court as part of a multidistrict litigation that claims various pharmaceutical companies conspired to fix drug prices.
The Detectives Endowment Association of the City of New York has filed a proposed class action in Pennsylvania against a collection of drug manufacturers.
A proposed class action alleges a who's who of major pharmaceutical companies engaged in a conspiracy to fix the prices of certain generic drugs.
The price of pravastatin tablets was artificially inflated as the result of an alleged price-fixing conspiracy between a group of major drug companies.
Generic drug makers continue to be the subject of class action litigation alleging they illegally colluded to fraudulently inflate prices of essential drugs.
California and Massachusetts consumers have filed a proposed class action against Mylan claiming the company illegally raised the EpiPen's price by more than 500 percent.